By a News Reporter-Staff News Editor at Biotech Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Repligen Corp. (Form CT ORDER) was posted on June 30, 2014.
The SIC code for this company is 2836, Biological Products, (No Diagnostic Substances).
There was one document filed with this form. The SEC file number is 9999999997-14-011582.
The contact information for this company is 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM MA 02453, 7814499560.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/730272/9999999997-14-011582-index.html.
Keywords for this news article include: SEC Filing, Repligen Corp., Biological Products, Biotechnology Companies, (No Diagnostic Substances).
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Read Next
